No Data
No Data
Ionis to Host 2025 Virtual Annual Meeting of Stockholders
Ionis Pharmaceuticals Independent Director Acquires 40% More Stock
Earnings Beat: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Director Makes Bold Move With Major Stock Purchase in Ionis Pharmaceuticals
Ionis Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations
A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $38 to $78